Inhibitors of farnesyl transferase: A new approach for the development of potential anticancer agents;Hemmstoffe der farnesyl-transferase: Ein neuer ansatz zur entwicklung potentieller krebstherapeutika

Pharmazie in Unserer Zeit

Volumn 27, Issue 6, 1998, Pages 278-288

  Schlitzer, Martin ^a,b,c,d  

^a Philipps Universität Marburg ^*  (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c WAYNE STATE UNIVERSITY   (United States)

^d Fachbereich Pharmazie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

10' DESMETHOXYSTREPTONIGRIN; 4 (8 CHLORO 5,6 DIHYDRO 11H BENZO[5,6]CYCLOHEPTA[1,2 B]PYRIDIN 11 YLIDENE) 1 (4 PYRIDYLACETYL)PIPERIDINE; ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLHISTIDYL(O BENZYLTYROSYL)(O BENZYLSERYL)TRYPTOPHYL DEXTRO ALANINAMIDE; CHAETOMELLIC ACID A; FTI 232; GLIOTOXIN; MANUMYCIN; N [2 [2 (2 AMINO 3 MERCAPTOPROPYLAMINO) 3 METHYLPENTYLOXY] 3 PHENYLPROPIONYL]METHIONINE SULFONE; PEPTICINNAMIN E; PREUSSOMERIN G; PROTEIN FARNESYLTRANSFERASE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RAS PROTEIN; UNCLASSIFIED DRUG; ENZYME INHIBITOR; FARNESYL TRANS TRANSFERASE; TRANSFERASE;

CANCER CHEMOTHERAPY; DRUG DEVELOPMENT; DRUG STRUCTURE; PROTEIN PROCESSING; REVIEW; ANIMAL; DRUG ANTAGONISM; ENZYMOLOGY; HUMAN; NEOPLASM; SYNTHESIS;

ALKYL AND ARYL TRANSFERASES; ANIMALS; ANTINEOPLASTIC AGENTS; ENZYME INHIBITORS; FARNESYLTRANSTRANSFERASE; HUMANS; NEOPLASMS;

EID: 0032217249     PISSN: 00483664     EISSN: None     Source Type: Journal    
DOI: 10.1002/pauz.19980270608     Document Type: Review

References (39)

1. Resch, K.; Schwabe, U. in Scholz, H.; Schwabe, U. (Hrsg.) Taschenbuch der Arzneibehandlung, 11. Aufl., Gustav Fischer Verlag, 1997, S. 306ff.
2. Travis, J.: Novel Anticancer Agents Move Close to Reality, Science 260 (1993), 1877-1878.
3. Gibbs, J.B.; Oliff, A.; Kohl, N.E.: Farnesyltransferase Inhibitors: Ras Research Yields a Potential Cancer Therapeutic, Cell 77 (1994), 175-178.
4. Leonhard, D.M.: Ras Farnesyltransferase: A New Therapeutic Target, J. Med. Chem. 40 (1997), 2971-2990.
5. Sebti, S.M., Hamilton, A.D.: New approaches to anticancer drug design based on the inhibition of farnesystransterase, Drug Discovery Today 3 (1998), 26-33
6. Cox, A.D.; Der, C.J.: Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?, Biochim. Biophys. Acta 1333 (1997), F51.
7. Gibbs, J.B.; Kohl, N E., Koblan, K.S.; Omer, C.A.; Sepp-Lorenzino, L.; Rosen, N.; Anthony, N.J.; Conner, M.W.; de Solms, S.J ; Williams, T.M.; Graham, S.L.; Hartmann, G.D.; Oliff, A.: Farnesyltransferase inhibitors and anti-Ras therapy, Breast Cancer Research and Treatment 38 (1996), 75-83
8. Gibbs, J B.; Oliff, A.: The Potential of Farnesyltransferaseinhibitors as Cancer Chemotherapeutics, Ann. Rev. Pharmacol. Toxicol. 37 (1997), 143-166.
9. Casey, P.J.; Seabra, M.C.: Protein Prenyltransferases, J. Biol. Chem. 271 (1996), 5289-5292.
10. Dolence, J.M.; Poulter, C.D.: A mechanism for posttranslational modifications of proteins by yeast protein farnesyltransferase, Proc. Natl. Acad. Sci. USA 92 (1995), 5008-5011.
11. Mu, Y.; Omer, C.A.; Gibbs, R.A.: On the Stereochemical Course of Human Protein-Farnesyl Transferase, J. Am. Chem. Soc. 118 (1996), 1817-1823.
12. Bhide, R.S., Patel, D.V.; Patel, M.M.; Robinson, S.P.; Hunihan, I. W.; Gordon, E.M.: Rational Design of Potent Carboxylic Acid Based Bisubstrate Inhibitors of Ras Farnesyl Protein Transferase, Bioorg. Med. Chem. Lett. 4 (1994), 2107-2112
13. Park, H.-W.; Boduluri, S.R.; Moomaw, J.F.; Casey, P.J.; Beese, L.S. Crystal Structure of Protein Farnesyltransferase at 2.25 Angstrom Resolution, Science 275 (1997), 1800-1804.
14. Ayral-Kaloustian, S.; Skotnicki, J.S.: Ras Farnesyltransferase Inhibitors, Ann. Rep. Med. Chem. 31 (1996), 171-181.
15. Singh, S.B.; Lingham, R.B.: Farnesyl-protein transferase inhibitors in early development, Exp. Opin. Invest Drugs 5 (1996), 1589-1599.
16. Graham, S.L.: Inhibitors of protein farnesylation: a new approach to cancer chemotherapy, Exp. Opin. Ther. Patents 5 (1995), 1269-1285.
17. Sattler, I.; Tamanoi, F. in Maruta, H.; Burgess, A.W. (Hrsg.) Regulation of the RAS signaling network, Springer Verlag, 1996, S. 95ff.
18. Bishop, W.R., Bond, R.; Petrin, J.; Wang, L.; Patton, R.; Doll, R.; Njoroge, G.; Catino, J.; Schwartz, J.; Windsor, W.; Syto, R.; Schwartz, J.; Carr, D.; James, L., Kirschmeier, P.: Novel Tricyclic Inhibitors of Farnesyl Protein Transferase, J. Biol. Chem. 270 (1995), 30611-30618.
19. Goldstein, J.L.; Brown, M.S.; Stradley, S.J.; Reiss, Y; Gierasch, L.M.: Nonfarnesylated Tetrapeptide Inhibitors of Protein Farnesyltransferase, J. Biol. Chem. 266 (1991), 15575-15578.
20. Garcia, A.M.; Rowell, C.; Ackermann, K.; Kowalczyk, Lewis, M.D.: Peptidomimetic Inhibitors of Ras Farnesylation and Function in Whole Cells, J. Biol. Chem. 268 (1993), 18415-18418.
21. Kohl, N.E.; Wilson, F.R.; Mosser, R.D.; Giuliani, E.; deSolms, S.J.; Conner, M.W.; Anthony, N.J.; Holtz, W.J.; Gomez, R.P.; Lee, T.-J.; Smith, R.L.; Graham, S.L.; Hartmann, G.D.; Gibbs, J.B.; Oliff, A.: Protein Farnesyltransferase inhibitors block the growth of Ras-dependent tumors in nude mice, Proc. Natl. Acad. Sci. USA 91 (1994), 9141-9145.
22. Leftheris, K.; Kline, T.; Vite, G.D.; Cho, Y.H.; Bhide, R.S.; Patel, D.V.; Patel, M.M.; Schmidt, R.J.; Weller, H.N.; Andahazy, M.L.; Carboni, J.M., Gullo-Brown, J.L.; Lee, F.Y.F.; Ricca, C.; Rose, W.C.; Barbacid, M.; Hunt, J.T.; Meyers, C.A.; Seizinger, B.R.; Zahler, R.; Manne, V.: Development of Highly Potent Inhibitors of Ras Fanesyltransferase Possessing Cellular an in Vivo Activity, J. Med. Chem. 39 (1996), 224-236.
23. Harrington, E.M.; Kowalczyk, J.J.; Pinnow, S.L.; Ackermann, K.; Garcia, A.M.; Lewis, M.D.: Cysteine and Methionine Linked by Carbon Pseudopeptides Inhibit Farnesyl Transferase, Bioorg. Med. Chem. Lett. 4 (1994), 12410-12413.
24. ras Farnesyltransferase, J. Biol. Chem. 269 (1994), 12410-12413.
25. Masters jr., J.C.; McDowell, R.L.; Reynolds, M.E.; Oare, D.A.; Somers, T.C.; Stanley, M.S.; Rawson, T.E.; Struble, M.E.; Burdick, D.J.; Chan, K.S.; Duarte, C.M.; Paris, K.J.; Tom, J.Y.K.; Wan, D.T.; Xue, Y.; Burnier, J.P.: Benzodiazepine Peptidomimetic Inhibitors of Farnesyltransferase, Bioorg. Med. Chem. Lett. 2 (1994), 949-957.
26. Qian, Y.; Vogt, A.; Sebti, S.M-; Hamilton, A.D.: Design and Synthesis of Non-Peptide Ras CAAX Mimetics as Potent Farnesyltransferase Inhibitors, J. Med. Chem. 39 (1996), 217-223.
27. deSolms, S.J.; Deana, A.A.; Giuliani, E.A.; Graham, S.L.; Kohl, N.E.; Mosser, S.D.; Oliff, A.I.; Pompliano, D.L.; Rands, E.; Scholz, T.H.; Wiggins, J.M.; Gibbs, J.B.; Smith, R.L.: Pseudopeptide Inhibitors of Protein Farnesyltransferase, Med. Chem. 38 (1995), 3967-3971.
28. Williams, T.M.; Ciccarone, T.M.; MacTough, S.C.; Bock, R.L.; Conner, M.W.; Davide, J.P.; Hamilton, K.; Koblan, K.S.; Kohl, N.E.; Kral, A.M.; Mosser, S.D.; Omer, C.A.; Pompliano, D.L.; Rands, E.; Schaber, M.D.; Shah, D.; Wilson, F.; Gibbs, J.B.; Graham, S.L.; Hartman, G.H.; Oliff, A.I.; Smith, R.L.: 2-Substituted Piperazines als Constrained Amino Acids. Application to the Synthesis of Potent, Non Carbxylic Acid Inhibitors of Farnesyltransferase, J. Med. Chem. 39 (1996), 1345-1348.
29. Patel, D.V.; Patel, M.M.; Robinson, S.S.; Gordon, E.M.: Phenol based Tripeptide Inhibitors of Ras Farnesyl Protein Transferase, Bioorg. Med. Chem. Lett. 4 (1994), 1883-1888.
30. Hunt, J,T.; Lee, V.G.; Leftheris, K.; Seizinger, B.; Carboni, J.; Mabus, J.; Ricca, C.; Yan, N.; Manne, V.: Potent, Cell Active, Non-Thiol Tetrapeptide Inhibitors of Farnesyltransfarese, J. Med. Chem. 39 (1996), 353-358.
31. deSolms, S.J.; Garsky, V.; Giuliani, E.; Gomez, R.P.; Graham, S.L.; Stokker, G.E.; Wiscount, C.M. (Merck & Co., Inc.): Preparation of peptide analogs as inhibitors of farnesyl-protein transferase, WO 9509,001, Apr. 1995.
32. Pompliano, D.L.; Rands, E.; Schaber, M.D.; Mosser, S.D.; Anthony, N.J.; Gibbs, J.B.: Steadystate kinetic mechanism of Ras farnesyl-protein transferase, Biochemistry 31 (1992), 3800-3807.
33. Patel, D.V.; Schmidt, R.J.; Biller, S.A.; Gordon, E.M.; Robinson, S.S.; Manne, V.: Farnesyl Diphosphat-Based Inhibitors of Ras Farnesyl Protein Transferase, J. Med. Chem. 38 (1995), 2906-2921.
34. Aoyama, T.; Satoh, T.; Yonemoto, M.; Shibata, J.; Nonoshita, K.; Arai, S.; Kawakami, K.; Iwasawa, Y.; Kodera, T.; Arakawa, H.; Suzuki-Takahashi, I.; Kamei, T.; Tomimoto, K.: A New Class of Highly Potent Farnesyl Diphosphate-Competitive Inhibitors of Farnesyltransferase, J. Med. Chem. 41 (1998), 143-147.
35. Schlitzer, M.; Sattler, I.: Manuskript in Vorbereitung.
36. Hinterding, K.; Hagenbuch, P.; Retey, J.; Waldmann, H.: Synthese und in-vitro-Evaluierung des Ras Fanesyltransferase-Inhibitors Pepticinnamin E, Angew. Chem. 110 (1998) 1298-1301.
37. Patel, D.V.; Gordon, E.M.; Schmidt, R.J.; Weller, H.N.; Young, M.G.; Zahler, R.; Barbacid, M.; Carboni, J.M.; Gullo-Brown, J.L.; Hunihan, L.; Ricca, C.; Robinson, S.; Seizinger, B.R.; Tuomari, A.V.; Manne, V.: Phosphinyl Acid-Based Bisubstrate Analog Inhibitors of ras Farnesyl Protein Transferase, J. Med. Chem. 38 (1995), 435-442.
38. Schlitzer, M.; Sattler, I.: Manuskript in Vorbereitung.
39. Rawls, R.L.: Puzzling Promise Of Protein Preylation, Chemistry and Engineering, News (1998), 67-69.